Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1.

[1]  H. Krum,et al.  Diagnostic and Therapeutic Potential of the Endothelin System in Patients with Chronic Heart Failure , 2001, Heart Failure Reviews.

[2]  K. Dickstein,et al.  Inhibition of both neutral endopeptidase and endothelin converting enzyme lowers pulmonary pressures in congestive heart failure , 2003 .

[3]  K. Webster,et al.  Molecular Regulation of the Endothelin-1 Gene by Hypoxia , 2001, The Journal of Biological Chemistry.

[4]  A. Ergul,et al.  Expression and activity of pulmonary endothelin converting enzyme in heart failure: relation to endothelin biosynthesis and receptor distribution. , 2001, Journal of cardiac failure.

[5]  T. Dschietzig,et al.  Pulmonary Release and Coronary and Peripheral Consumption of Big Endothelin and Endothelin-1 in Severe Heart Failure: Acute Effects of Vasodilator Therapy , 2000, Circulation.

[6]  M. Kinoshita,et al.  Transcardiac extraction of circulating endothelin-1 across the failing heart. , 2000, The American journal of cardiology.

[7]  H. Neumayer,et al.  Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. , 2000, American journal of respiratory cell and molecular biology.

[8]  O. Smiseth,et al.  Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF. , 2000, American journal of physiology. Heart and circulatory physiology.

[9]  M. Kinoshita,et al.  Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure. , 1999, Journal of the American College of Cardiology.

[10]  J. Rouleau,et al.  Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction. , 1998, Circulation.

[11]  J. Tardif,et al.  Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. , 1998, American heart journal.

[12]  Y. Sugishita,et al.  Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? , 1997, Life sciences.

[13]  M. Yanagisawa,et al.  In vivo role of endothelin-converting enzyme-1 as examined by adenovirus-mediated overexpression in rats. , 1998, Journal of cardiovascular pharmacology.

[14]  F. Pinet,et al.  Construction, expression and characterization of a soluble form of human endothelin‐converting‐enzyme‐1 , 1997, FEBS letters.

[15]  O. Smiseth,et al.  Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats. , 1997, American journal of physiology. Heart and circulatory physiology.

[16]  D. Stewart,et al.  Human pulmonary circulation is an important site for both clearance and production of endothelin-1. , 1996, Circulation.

[17]  C. Goresky,et al.  Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. , 1996, Journal of applied physiology.

[18]  M. Yanagisawa,et al.  Endothelin-converting Enzyme-2 Is a Membrane-bound, Phosphoramidon-sensitive Metalloprotease with Acidic pH Optimum (*) , 1995, The Journal of Biological Chemistry.

[19]  M. Yanagisawa,et al.  ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1 , 1994, Cell.

[20]  R. T. Lie,et al.  Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. , 1994, Circulation.

[21]  W. Edwards,et al.  Endothelin in human congestive heart failure. , 1994, Circulation.

[22]  D. Stewart,et al.  Pulmonary removal and production of endothelin in the anesthetized dog. , 1994, Journal of applied physiology.

[23]  A. Lerman,et al.  Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. , 1992, Journal of the American College of Cardiology.

[24]  J. McMurray,et al.  Plasma Endothelin in Chronic Heart Failure , 1992, Circulation.

[25]  A. Lerman,et al.  Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.

[26]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.